SCHEMBL3479738

SCHEMBL3479738

CN1CCN(c2ccc(F)cc2)c2ccc(-c3ncns3)cc2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.43
HRH4 Q9H3N8 3/20 0.35
MAPKAPK2 P49137 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
ALDH1A1 P00352 1/20 0.34
TACR3 P29371 1/20 0.34
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RECQL P46063 1/20 0.33
PTK2B Q14289 1/20 0.33
AXL P30530 1/20 0.32
RPS6KA3 P51812 1/20 0.32
TERT O14746 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
BLM P54132 1/20 0.32
TAAR1 Q96RJ0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3229546 0.91 SCN9A (0.39) SCN9AHRH4L3MBTL1ALDH1A1TACR3
SCHEMBL3227917 0.89 SCN9A (0.40) SCN9AMAPTKDM4EGAAMAPK1
SCHEMBL3479957 0.89 SCN9A (0.41) SCN9AHRH4MAPKAPK2ALDH1A1MAPT
SCHEMBL3479711 0.89 SCN9A (0.42) SCN9AHRH4ALDH1A1MAPTKDM4E
SCHEMBL3479736 0.84 HTR3A (0.41) SCN9AHRH4MAPTKDM4ETERT
SCHEMBL3237557 0.83 SCN9A (0.43) SCN9AHRH4MAPKAPK2L3MBTL1ALDH1A1
SCHEMBL3227589 0.80 SCN9A (0.43) SCN9AHRH4MAPKAPK2L3MBTL1ALDH1A1
SCHEMBL3232247 0.80 SCN9A (0.48) SCN9AHRH4MAPKAPK2L3MBTL1ALDH1A1
SCHEMBL3234663 0.80 DRD2 (0.47) SCN9AHRH4MAPKAPK2L3MBTL1ALDH1A1
SCHEMBL3479628 0.78 SCN9A (0.48) SCN9AHRH4MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D SCN9A 795/4885HRH4 90/4885MAPKAPK2 4505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.